What are the strategies for preserving the effectiveness of existing antibiotics?

May 5, 2017 ... No clinical information was available about the patients from whom the cultures were taken. The identity and antimicrobial drug susceptibility ... Jun 9, 2023 ... Background: Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae threaten infection treatment globally. This study aims to ... Methods This study analyzed 632 clinical strains (44% ESBL, 56% non-ESBL producers) of Enterobacteriaceae consisting of Escherichia coli, Klebsiella pneumoniae ... Dec 6, 2011 ... done for ESBLs confirmation. During this study, the type of ESBL gene was determined by polymerase chain reaction. (Table 5) which showed ... Jan 8, 2021 ... However, clinical information with respect to its utilization in infection caused by ESBL producers is limited. The aim of this study was a ... In this study we aimed to investigate in vitro activity of meropenem, ciprofloxacine and amikacin against ESBL-producing and non-producing blood isolates. Sep 30, 2019 ... pneumoniae isolates, the most prevalent gene was fimH (76%), uge (70%). There was significant association between ESBL production, and ... These percentages are similar to our data. Prior antibiotic use was the risk factor for ESBL-producing Escherichia coli or Klebsiella pneumoniae infection [20]. Apr 22, 2025 ... To Study the Prevalence of Extended-Spectrum β-lactamases (ESBL) Producing Uropathogenic Escherichia coli (UPEC) and its Antibiotic Sensitivity ... Nov 7, 2017 ... This study aims to find the prevalence of MDR and ESBL producing isolates from chicken meat in Bharatpur metropolitan.